Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,430 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

NCT01814488

Conditions
Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy
  • Policlinico Bari, Italy
  • Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy
  • Ospedale San Orsola Bologna, Italy
View all 30 locations
View Trial Details
Completed

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

NCT00354120

Conditions
Acute Myeloblastic Leukemia, Anemia, Anemia, Refractory, +28 more
Locations
  • Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy
  • Divisione Ematologia - Ospedale "SS. Antonio, Biagio e Cesare Arrigo" Alessandria, Italy
  • Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy
  • Divisione di Ematologia - Ospedali Riuniti Bergamo Bergamo, Italy
View all 22 locations
View Trial Details
Completed

Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients

NCT02845297

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
  • University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States
View Trial Details
Completed

The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)

NCT02269267

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Helen Diller Family Comprehensive Cancer Center University of California San Francisco, California, United States
  • Moffit Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Chicago Chicago, Illinois, United States
View all 16 locations
View Trial Details
Completed

Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT01238211

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +13 more
Locations
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Saint Joseph Medical Center Bloomington, Illinois, United States
View all 65 locations
View Trial Details
Completed

An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)

NCT02775903

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 103 locations
View Trial Details
Completed

Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

NCT01420926

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Hematologic Diseases, +7 more
Locations
  • Palo Alto Medical Foundation-Camino Division Mountain View, California, United States
  • Hartford Hospital Hartford, Connecticut, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
View all 53 locations
View Trial Details
Completed

Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)

NCT03303339

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • Allina Health Virginia Piper Cancer Institute Minneapolis, Minnesota, United States
View Trial Details
Completed

Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation

NCT00893399

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Medizinische Universitäts Graz Graz, Austria
  • Universitätsklinikum Innsbruck Innsbruck, Austria
  • Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H. Linz, Austria
  • Krankenhaus der Barmherzigen Schwestern Linz Linz, Austria
View all 60 locations
View Trial Details

Related conditions